Pharmacokinetic analysis of multi PEG-theophylline conjugates

In the attempt of prolonging the effect of drugs, a new branched, high-molecular weight multimeric poly(ethylene glycol) (MultiPEG), synthesized with a simple assembling procedure that devised the introduction of functional groups with divergent and selective reactivity, was employed as drug carrier. In particular, the attention was focused on the study of theophylline (THEO) and THEO-MultiPEG conjugates pharmacokinetic after oral administration in rabbit. Pharmacokinetic behavior was studied according to an ad hoc developed mathematical model accounting for THEO-MultiPEG in vivo absorption and decomposition into drug (THEO) and carrier (MultiPEG). The branched high-molecular weight MultiPEG proved to be a reliable drug delivery system able to prolong theophylline staying in the blood after oral administration of a THEO-MultiPEG solution. The analysis of experimental data by means of the developed mathematical model revealed that the prolongation of THEO effect was essentially due to the low THEO-MultiPEG permeability in comparison to that of pure THEO.

[1]  New Syntheses of Branched, Multifunctional High-Molecular Weight Poly(ethylene glycol)s or (MultiPEG)s , 2008 .

[2]  Sang -Geon Kim,et al.  Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  B. Perissutti,et al.  Preparation of sustained release co-extrudates by hot-melt extrusion and mathematical modelling of in vitro/in vivo drug release profiles. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  S. Zorzet,et al.  Improvement of physicochemical and biopharmaceutical properties of theophylline by poly(ethylene glycol) conjugates. , 2003, Farmaco.

[5]  Romano Lapasin,et al.  Understanding Drug Release and Absorption Mechanisms: A Physical and Mathematical Approach , 2006 .

[6]  R. Ogilvie,et al.  Pharmacokinetics of intravenous theophylline , 1973, Clinical pharmacology and therapeutics.

[7]  A. Fishman,et al.  Synthesis and investigation of novel branched PEG-based soluble polymer supports. , 2003, The Journal of organic chemistry.

[8]  M. L. Johnson,et al.  Parameter correlations while curve fitting. , 2000, Methods in enzymology.

[9]  M. Bonati,et al.  Pharmacokinetics of theophylline and its metabolites in rabbits , 1985, European Journal of Drug Metabolism and Pharmacokinetics.

[10]  D. Breimer,et al.  Zero-order rectal delivery of theophylline in man with an osmotic system , 1982, Journal of Pharmacokinetics and Biopharmaceutics.

[11]  F. Szoka,et al.  PEGylated dendrimers with core functionality for biological applications. , 2008, Bioconjugate chemistry.

[12]  G. Bonora,et al.  New MultiPEG-conjugated theophylline derivatives: synthesis and pharmacological evaluations. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[13]  G. Bonora,et al.  MultiPEGs: High Molecular Weight Multifunctional Poly(ethylene glycol)s Assembled by a Dendrimer‐Like Approach , 2005 .

[14]  T. Kararli Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.

[15]  J. Fréchet,et al.  Dendrimers and dendritic polymers in drug delivery. , 2005, Drug discovery today.